Clinical Trials in Athens, Attica

Pan Tumor Rollover Study

NCT ID: NCT03899155

The Pan Tumor Rollover Study is a clinical trial focused on understanding the long-term safety of a cancer treatment called nivolumab, both on its own and in combination with other therapies. This ...

Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

NCT ID: NCT05605093

The STRIVE clinical trial is studying a new treatment called ensitrelvir for patients hospitalized with COVID-19. This treatment aims to help improve recovery by targeting the virus that causes COV...

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

NCT ID: NCT06472245

This clinical trial is studying a new cancer vaccine called OSE2101 for patients with non-small cell lung cancer (NSCLC) who have not responded well to previous treatments with immune checkpoint in...

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus

NCT ID: NCT05352919

Outpatient Treatment With Anti-Coronavirus Immunoglobulin

NCT ID: NCT04910269

The Outpatient Treatment with Anti-Coronavirus Immunoglobulin (OTAC) trial is studying a new treatment for COVID-19. Specifically, it aims to see if a single infusion of a special type of antibody ...

The Effect of Inspiratory Muscle Training in People With Gastroesophageal Reflux Disease

NCT ID: NCT07131397

This clinical trial is studying whether a special breathing exercise called Inspiratory Muscle Training (IMT) can help people with gastroesophageal reflux disease (GERD), a condition where stomach ...

Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

NCT ID: NCT05156281

This clinical trial is studying the effectiveness and safety of a new treatment called remibrutinib compared to an existing drug, teriflunomide, in people with relapsing multiple sclerosis (RMS). R...

Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)

NCT ID: NCT06117774

This clinical trial is studying a new treatment called tarlatamab for patients with limited-stage small cell lung cancer (LS-SCLC) who have already received chemotherapy and radiation therapy. The ...

REZILIENT3 (REsearching ZIpaLertinib In Egfr Non-small Cell Lung Cancer Tumors)

NCT ID: NCT05973773

The REZILIENT3 clinical trial is studying a new drug called zipalertinib to see how well it works when combined with standard chemotherapy in treating advanced non-small cell lung cancer (NSCLC) th...

Tirzepatide vs Liraglutide in Bone

NCT ID: NCT07094568

This clinical trial is studying how two different medications, tirzepatide and liraglutide, affect bone health and body composition in adults with severe obesity (a Body Mass Index, or BMI, of 40 o...

A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments

NCT ID: NCT05137054

This clinical trial is testing a new treatment called linvoseltamab for adults with multiple myeloma, a type of blood cancer that has not responded to standard therapies. The study will explore how...

The Crohn's Disease Exclusion Diet With Early Dairy Introduction vs Partial Enteral Nutrition for Crohn's Disease

NCT ID: NCT05606419

This clinical trial is investigating a new diet called the Crohn's Disease Exclusion Diet (CDED) for adults with Crohn's disease, a condition that causes inflammation in the digestive tract. The st...

Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial)

NCT ID: NCT05909683

The MODIFY Trial is a clinical study that aims to improve the treatment of severe infections, specifically sepsis, which is a serious condition caused by the body's response to infection. This tria...

Evaluation of a High Protein Plant Dominant Diet (HiProPlaDo) in Liver Cirrhosis

NCT ID: NCT07028580

This clinical trial is studying how a high-protein diet made mostly from plant-based foods compares to the usual diet for people with liver cirrhosis, which typically includes protein from low-fat ...

Observational Study Protocol: LIVER-R

NCT ID: NCT06252753

The LIVER-R study is a clinical trial aimed at understanding how effective a treatment called durvalumab is for patients with certain types of liver and bile duct cancers. This study will gather in...

25(OH)-Vitamin D and Its Association With Structural and Functional Parameters in Hospitalized Patients With Neurological Diseases

NCT ID: NCT06791044

The NeuroVitD study is looking at the levels of vitamin D in hospitalized patients with neurological conditions, like strokes and spinal cord injuries, who may not have enough vitamin D. The main g...

Role of Tryptase Levels in Patients With Stable Coronary Artery Disease.

NCT ID: NCT06958016

This clinical trial is looking at a substance called tryptase in patients who have stable coronary artery disease, a condition that affects the blood vessels supplying the heart. The researchers wa...

Lysosomal Acid Lipase (LAL) Deficiency Registry

NCT ID: NCT01633489

The Lysosomal Acid Lipase (LAL) Deficiency Registry is a research study aimed at better understanding and improving the care for patients with LAL Deficiency and related conditions. This study is o...

First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis.

NCT ID: NCT06946498

This clinical trial is investigating a new way to diagnose pleural effusion, which is a buildup of fluid in the space around the lungs. The study specifically looks at patients who may have cancer-...

Study of Selinexor in Combination with Ruxolitinib in Myelofibrosis

NCT ID: NCT04562389

This clinical trial is studying a new combination of two medications, selinexor and ruxolitinib, to see if they can effectively treat myelofibrosis (MF), a type of bone marrow cancer. The trial has...